New combo therapy tested for tough pancreatic cancer

This early-stage study tested whether combining a procedure that uses electrical pulses to destroy tumors (IRE) with an immunotherapy drug (pembrolizumab) is safe for people with locally advanced pancreatic cancer that cannot be removed by surgery. Only 2 participants were enrolled. The main goal was to check for serious side effects, not to measure how well the treatment works.